Report Description

Middle East & North Africa Veterinary Pharmaceuticals Market will grow in the coming years with an impressive CAGR. The growing affection for pets and increased public knowledge of animal health both will contribute to the growth of the Middle East and North Africa Veterinary Pharmaceuticals market. Additionally, an increase in infectious disorders is expected to promote market expansion in the upcoming years.

Additionally, expanding livestock production, increased meat consumption, and an increase in the incidence of zoonotic illness are driving the growth of the Middle East & North America Veterinary Pharmaceuticals market in the coming years.

In the upcoming years, the Middle East, and North Africa Veterinary Pharmaceuticals market might face challenge from high costs connected with animal services, a lack of infrastructure, rising costs associated with animal testing, and strict restrictions surrounding the use of antibiotics.

 

Increasing Cases of Infectious Diseases in Animals 

The main threat to livestock health is infectious diseases through rickettsia, viruses, bacteria, and fungus. Some protozoan diseases exhibit similar symptoms of infectious diseases and are frequently categorized. Consumption of contaminated food or water with pathogenic (disease-causing) microorganisms as bacteria, viruses, and parasites is the main cause of infectious disorders. After entering the body, they typically start to cause symptoms in the gastrointestinal tract. Contamination is a possibility along the entire food chain, from farm to fork, necessitating management and prevention.  Animal diseases are brought on by bacteria, viruses, parasites, fungus, malnutrition, chemical poisons, etc. The Middle East & North Africa market is expected to grow more quickly in the next years due to the rising occurrence of infectious diseases in animals.

 

Increasing the Adoption of Pets

To aid animals in need of food and shelter, many people are adopting dogs. Pet rescue organizations and animal shelters are overflowing with contented, healthy animals waiting for a home. One strategy to combat puppy mills is pet adoption. Pet owners who purchase animals from a pet shop, an online vendor, or a flea market are moreover purchasing a dog from a puppy mill. Factory-style breeding operations known as puppy mills priorities financial gain over the wellbeing of the canines. Puppy mill animals are kept in abhorrently deficient conditions with inadequate medical attention; as a result, they frequently have severe illnesses and behavioral problems. The growth of the Middle East & North Africa Veterinary Pharmaceuticals market in the anticipated years is being supported by rising concerns over pet adoption and increased awareness of animal healthcare.




Download Free Sample Report 


Market Segmentation

Middle East & North Africa Veterinary Pharmaceuticals Market can be segmented by animal and product. Based on animal segment, the market can be further divided into livestock animals, poultry and pets. Based on livestock animals, the market is sub-divided into equine, bovine & camel, ovine, and caprine. Based on poultry, the market is sub-divided into breeders and broilers. Based on pets, the market is sub-divided into canine and feline. Based on product, the market is divided into antibacterial, anthelmintics, anticoccidials, anti-inflammatories, metabolic enhancers, and nutritional supplements. Based on antibacterial, the market is further sub-divided into water soluble powder, oral solutions, feed premixes, injectables, and others. Based on anthelmintics, the market is further sub-segmented into oral powder, oral suspensions, injectables, and others. Based on anticoccidials, the market is further sub-divided into oral solutions, feed premixes, and others.

 

Market Players

United Company For Veterinary Medicines Industry (UNIVET), MSD Animal Health, Al Mutawwaj Veterinary Pharmaceutical Industries, Boehringer Ingelheim Ltd., VAPCO Manufacturing CO. Ltd., AlQuds Pharmaceutical Group, Megavet Veterinary Medicine LLC, The Arab Pesticides and Veterinary Drugs Mfg.Co (Mobedco), Saudi Pharmaceutical Industries, Virbac Group are some of the leading players operating in the Middle East & North Africa Veterinary Pharmaceuticals Market.


Attribute

Details

Base Year

2022

Historic Data

2018 – 2021

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028

Report coverage

Revenue forecast, volume forecast, company share, competitive landscape, growth factors, and trends

Segments covered

By Animal

By Product

Country scope

Saudi Arabia, UAE, Kuwait, Qatar, Oman, Bahrain, Egypt, Algeria, Morocco, Tunisia

Key companies profiled

United Company For Veterinary Medicines Industry (UNIVET), MSD Animal Health, Al Mutawwaj Veterinary Pharmaceutical Industries, Boehringer Ingelheim Ltd., VAPCO Manufacturing CO. Ltd., AlQuds Pharmaceutical Group, Megavet Veterinary Medicine LLC, The Arab Pesticides and Veterinary Drugs Mfg.Co (Mobedco), Saudi Pharmaceutical Industries, Virbac Group

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Report Scope:

In this report, Middle East & North Africa Veterinary Pharmaceuticals Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Middle East & North Africa Veterinary Pharmaceuticals Market, By Animal:

o      Livestock Animals (Equine, Bovine & Camel, Ovine, Caprine)

o      Poultry (Breeders, Broilers)

o      Pets (Canine, Feline)

            ·         Middle East & North Africa Veterinary Pharmaceuticals Market, By Product:

o      Antibacterial (Water Soluble Powder, Oral Solutions, Feed Premixes, Injectables, Others)

o      Anthelmintics (Oral Powder, Oral Suspensions, Injectables, Others)

o      Anticoccidials (Oral Solutions, Feed Premixes, Others)

o      Anti-inflammatories

o      Metabolic Enhancers

o      Nutritional Supplements

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Middle East & North Africa Veterinary Pharmaceuticals Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Middle East & North Africa Veterinary Pharmaceuticals Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.     Markets Covered

1.2.2.     Years Considered for Study

1.2.3.     Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Impact of COVID-19 on Middle East & North Africa Pharmaceuticals Market

5.    Middle East & North Africa Pharmaceuticals Market Outlook

5.1.  Market Size & Forecast

5.1.1.     By Value

5.2.  Market Share & Forecast

5.2.1.     By Animal (Livestock Animals, Poultry, Pets)

5.2.1.1.         By Livestock Animals (Equine, Bovine & Camel, Ovine, Caprine)

5.2.1.2.         By Poultry (Breeders, Broilers)

5.2.1.3.         By Pets (Canine, Feline)

5.2.2.     By Product (Antibacterial, Anthelmintics, Anticoccidials, Anti-inflammatories, Metabolic Enhancers, Nutritional Supplements)

5.2.2.1.         By Antibacterial (Water Soluble Powder, Oral Solutions, Feed Premixes, Injectables, Others)

5.2.2.2.         By Anthelmintics (Oral Powder, Oral Suspensions, Injectables, Others)

5.2.2.3.         By Anticoccidials (Oral Solutions, Feed Premixes, Others)

5.2.3.     By Country

5.2.4.     By Company (2022)

5.3.  Market Map

5.3.1.     By Animal

5.3.2.     By Product

5.3.3.     By Country

5.4.  Middle East & North Africa: Country Analysis

5.4.1.     Saudi Arabia Veterinary Pharmaceuticals Market Outlook

5.4.1.1.         Market Size & Forecast

5.4.1.1.1.             By Value

5.4.1.2.         Market Share & Forecast

5.4.1.2.1.             By Animal (Livestock Animals, Poultry, Pets)

5.4.1.2.1.1. By Livestock Animals (Equine, Bovine & Camel, Ovine, Caprine)

5.4.1.2.1.2. By Poultry (Breeders, Broilers)

5.4.1.2.1.3. By Pets (Canine, Feline)

5.4.1.2.2.             By Product (Antibacterial, Anthelmintics, Anticoccidials, Anti-inflammatories, Metabolic Enhancers, Nutritional Supplements)

5.4.1.2.2.1. By Antibacterial (Water Soluble Powder, Oral Solutions, Feed Premixes, Injectables, Others)

5.4.1.2.2.2. By Anthelmintics (Oral Powder, Oral Suspensions, Injectables, Others)

5.4.1.2.2.3. By Anticoccidials (Oral Solutions, Feed Premixes, Others)

5.4.2.     UAE Veterinary Pharmaceuticals Market Outlook

5.4.2.1.         Market Size & Forecast

5.4.2.1.1.             By Value

5.4.2.2.         Market Share & Forecast

5.4.2.2.1.             By Animal (Livestock Animals, Poultry, Pets)

5.4.2.2.1.1. By Livestock Animals (Equine, Bovine & Camel, Ovine, Caprine)

5.4.2.2.1.2. By Poultry (Breeders, Broilers)

5.4.2.2.1.3. By Pets (Canine, Feline)

5.4.2.2.2.             By Product (Antibacterial, Anthelmintics, Anticoccidials, Anti-inflammatories, Metabolic Enhancers, Nutritional Supplements)

5.4.2.2.2.1. By Antibacterial (Water Soluble Powder, Oral Solutions, Feed Premixes, Injectables, Others)

5.4.2.2.2.2. By Anthelmintics (Oral Powder, Oral Suspensions, Injectables, Others)

5.4.2.2.2.3. By Anticoccidials (Oral Solutions, Feed Premixes, Others)

5.4.3.     Kuwait Veterinary Pharmaceuticals Market Outlook

5.4.3.1.         Market Size & Forecast

5.4.3.1.1.             By Value

5.4.3.2.         Market Share & Forecast

5.4.3.2.1.             By Animal (Livestock Animals, Poultry, Pets)

5.4.3.2.1.1. By Livestock Animals (Equine, Bovine & Camel, Ovine, Caprine)

5.4.3.2.1.2. By Poultry (Breeders, Broilers)

5.4.3.2.1.3. By Pets (Canine, Feline)

5.4.3.2.2.             By Product (Antibacterial, Anthelmintics, Anticoccidials, Anti-inflammatories, Metabolic Enhancers, Nutritional Supplements)

5.4.3.2.2.1. By Antibacterial (Water Soluble Powder, Oral Solutions, Feed Premixes, Injectables, Others)

5.4.3.2.2.2. By Anthelmintics (Oral Powder, Oral Suspensions, Injectables, Others)

5.4.3.2.2.3. By Anticoccidials (Oral Solutions, Feed Premixes, Others)

5.4.4.     Qatar Veterinary Pharmaceuticals Market Outlook

5.4.4.1.         Market Size & Forecast

5.4.4.1.1.             By Value

5.4.4.2.         Market Share & Forecast

5.4.4.2.1.             By Animal (Livestock Animals, Poultry, Pets)

5.4.4.2.1.1. By Livestock Animals (Equine, Bovine & Camel, Ovine, Caprine)

5.4.4.2.1.2. By Poultry (Breeders, Broilers)

5.4.4.2.1.3. By Pets (Canine, Feline)

5.4.4.2.2.             By Product (Antibacterial, Anthelmintics, Anticoccidials, Anti-inflammatories, Metabolic Enhancers, Nutritional Supplements)

5.4.4.2.2.1. By Antibacterial (Water Soluble Powder, Oral Solutions, Feed Premixes, Injectables, Others)

5.4.4.2.2.2. By Anthelmintics (Oral Powder, Oral Suspensions, Injectables, Others)

5.4.4.2.2.3. By Anticoccidials (Oral Solutions, Feed Premixes, Others)

5.4.5.     Oman Veterinary Pharmaceuticals Market Outlook

5.4.5.1.         Market Size & Forecast

5.4.5.1.1.             By Value

5.4.5.2.         Market Share & Forecast

5.4.5.2.1.             By Animal (Livestock Animals, Poultry, Pets)

5.4.5.2.1.1. By Livestock Animals (Equine, Bovine & Camel, Ovine, Caprine)

5.4.5.2.1.2. By Poultry (Breeders, Broilers)

5.4.5.2.1.3. By Pets (Canine, Feline)

5.4.5.2.2.             By Product (Antibacterial, Anthelmintics, Anticoccidials, Anti-inflammatories, Metabolic Enhancers, Nutritional Supplements)

5.4.5.2.2.1. By Antibacterial (Water Soluble Powder, Oral Solutions, Feed Premixes, Injectables, Others)

5.4.5.2.2.2. By Anthelmintics (Oral Powder, Oral Suspensions, Injectables, Others)

5.4.5.2.2.3. By Anticoccidials (Oral Solutions, Feed Premixes, Others)

5.4.6.     Bahrain Veterinary Pharmaceuticals Market Outlook

5.4.6.1.         Market Size & Forecast

5.4.6.1.1.             By Value

5.4.6.2.         Market Share & Forecast

5.4.6.2.1.             By Animal (Livestock Animals, Poultry, Pets)

5.4.6.2.1.1. By Livestock Animals (Equine, Bovine & Camel, Ovine, Caprine)

5.4.6.2.1.2. By Poultry (Breeders, Broilers)

5.4.6.2.1.3. By Pets (Canine, Feline)

5.4.6.2.2.             By Product (Antibacterial, Anthelmintics, Anticoccidials, Anti-inflammatories, Metabolic Enhancers, Nutritional Supplements)

5.4.6.2.2.1. By Antibacterial (Water Soluble Powder, Oral Solutions, Feed Premixes, Injectables, Others)

5.4.6.2.2.2. By Anthelmintics (Oral Powder, Oral Suspensions, Injectables, Others)

5.4.6.2.2.3. By Anticoccidials (Oral Solutions, Feed Premixes, Others)

5.4.7.     Egypt Veterinary Pharmaceuticals Market Outlook

5.4.7.1.         Market Size & Forecast

5.4.7.1.1.             By Value

5.4.7.2.         Market Share & Forecast

5.4.7.2.1.             By Animal (Livestock Animals, Poultry, Pets)

5.4.7.2.1.1. By Livestock Animals (Equine, Bovine & Camel, Ovine, Caprine)

5.4.7.2.1.2. By Poultry (Breeders, Broilers)

5.4.7.2.1.3. By Pets (Canine, Feline)

5.4.7.2.2.             By Product (Antibacterial, Anthelmintics, Anticoccidials, Anti-inflammatories, Metabolic Enhancers, Nutritional Supplements)

5.4.7.2.2.1. By Antibacterial (Water Soluble Powder, Oral Solutions, Feed Premixes, Injectables, Others)

5.4.7.2.2.2. By Anthelmintics (Oral Powder, Oral Suspensions, Injectables, Others)

5.4.7.2.2.3. By Anticoccidials (Oral Solutions, Feed Premixes, Others)

5.4.8.     Algeria Veterinary Pharmaceuticals Market Outlook

5.4.8.1.         Market Size & Forecast

5.4.8.1.1.             By Value

5.4.8.2.         Market Share & Forecast

5.4.8.2.1.             By Animal (Livestock Animals, Poultry, Pets)

5.4.8.2.1.1. By Livestock Animals (Equine, Bovine & Camel, Ovine, Caprine)

5.4.8.2.1.2. By Poultry (Breeders, Broilers)

5.4.8.2.1.3. By Pets (Canine, Feline)

5.4.8.2.2.             By Product (Antibacterial, Anthelmintics, Anticoccidials, Anti-inflammatories, Metabolic Enhancers, Nutritional Supplements)

5.4.8.2.2.1. By Antibacterial (Water Soluble Powder, Oral Solutions, Feed Premixes, Injectables, Others)

5.4.8.2.2.2. By Anthelmintics (Oral Powder, Oral Suspensions, Injectables, Others)

5.4.8.2.2.3. By Anticoccidials (Oral Solutions, Feed Premixes, Others)

5.4.9.     Morocco Veterinary Pharmaceuticals Market Outlook

5.4.9.1.         Market Size & Forecast

5.4.9.1.1.             By Value

5.4.9.2.         Market Share & Forecast

5.4.9.2.1.             By Animal (Livestock Animals, Poultry, Pets)

5.4.9.2.1.1. By Livestock Animals (Equine, Bovine & Camel, Ovine, Caprine)

5.4.9.2.1.2. By Poultry (Breeders, Broilers)

5.4.9.2.1.3. By Pets (Canine, Feline)

5.4.9.2.2.             By Product (Antibacterial, Anthelmintics, Anticoccidials, Anti-inflammatories, Metabolic Enhancers, Nutritional Supplements)

5.4.9.2.2.1. By Antibacterial (Water Soluble Powder, Oral Solutions, Feed Premixes, Injectables, Others)

5.4.9.2.2.2. By Anthelmintics (Oral Powder, Oral Suspensions, Injectables, Others)

5.4.9.2.2.3. By Anticoccidials (Oral Solutions, Feed Premixes, Others)

5.4.10.  Tunisia Veterinary Pharmaceuticals Market Outlook

5.4.10.1.      Market Size & Forecast

5.4.10.1.1.           By Value

5.4.10.2.      Market Share & Forecast

5.4.10.2.1.           By Animal (Livestock Animals, Poultry, Pets)

5.4.10.2.1.1.               By Livestock Animals (Equine, Bovine & Camel, Ovine, Caprine)

5.4.10.2.1.2.               By Poultry (Breeders, Broilers)

5.4.10.2.1.3.               By Pets (Canine, Feline)

5.4.10.2.2.           By Product (Antibacterial, Anthelmintics, Anticoccidials, Anti-inflammatories, Metabolic Enhancers, Nutritional Supplements)

5.4.10.2.2.1.               By Antibacterial (Water Soluble Powder, Oral Solutions, Feed Premixes, Injectables, Others)

5.4.10.2.2.2.               By Anthelmintics (Oral Powder, Oral Suspensions, Injectables, Others)

5.4.10.2.2.3.               By Anticoccidials (Oral Solutions, Feed Premixes, Others)

6.    Market Dynamics

6.1.  Drivers

6.2.  Challenges

7.    Market Trends & Developments

7.1.  Recent Developments

7.2.  Mergers & Acquisitions

7.3.  Product Launches

8.    Porter’s Five Forces Analysis

8.1.  Competition in the Industry

8.2.  Potential of New Entrants

8.3.  Power of Suppliers

8.4.  Power of Customers

8.5.  Threat of Substitute Products

9.    Competitive Landscape

9.1.  Business Overview

9.2.  Product Offerings

9.3.  Recent Developments

9.4.  Financials (As Reported)

9.5.  Key Personnel

9.6.  SWOT Analysis

9.6.1.     United Company For Veterinary Medicines Industry (UNIVET)

9.6.2.     MSD Animal Health 

9.6.3.     Al Mutawwaj Veterinary Pharmaceutical Industries

9.6.4.     Boehringer Ingelheim Ltd.

9.6.5.     VAPCO Manufacturing CO. Ltd.

9.6.6.     AlQuds Pharmaceutical Group

9.6.7.     Megavet Veterinary Medicine LLC

9.6.8.     The Arab Pesticides and Veterinary Drugs Mfg.Co (Mobedco)

9.6.9.     Saudi Pharmaceutical Industries

9.6.10.  Virbac Group

10.  Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

Increased incidences of infectious diseases in animals, growing production of livestock, increasing number of veterinary hospitals, rising awareness among people regarding the animal healthcare are among the major factors influencing the growth of veterinary pharmaceuticals market in Middle East & North Africa.

down-arrow

United Company For Veterinary Medicines Industry (UNIVET), MSD Animal Health, Al Mutawwaj Veterinary Pharmaceutical Industries, Boehringer Ingelheim Ltd., VAPCO Manufacturing CO. Ltd., AlQuds Pharmaceutical Group, Megavet Veterinary Medicine LLC, The Arab Pesticides and Veterinary Drugs Mfg.Co (Mobedco), Saudi Pharmaceutical Industries, Virbac Group are some of the leading players operating in the Middle East & North Africa Veterinary Pharmaceuticals Market.

down-arrow

Livestock animals are expected to dominate the Middle East & North Africa Veterinary Pharmaceuticals market in forecasted years due to the rising production of livestock animals.

down-arrow

Rising cost of animal testing, high cost associated with animal services, lack of infrastructure, lack of awareness related to veterinary healthcare among others are the major challenges, the Middle East & North Africa Market will face in coming years.

profile

Sakshi Bajaal

Business Consultant
Press Release

Middle East & North Africa Veterinary Pharmaceuticals Market to be dominated by the growing incidences of infectious diseases through 2028.

Apr, 2023

Increasing number of infectious diseases and rising pet adoption will drive the growth of Middle East & North Africa Veterinary Pharmaceuticals Market in the forecast period, 2024-2028.